Sign in
Taking people in United StatesPhase 3

Gabapentin to prevent opioid use for mouth sore pain in head and neck cancer

Tests gabapentin against placebo for mouth-sore pain in adults with head and neck cancer.

Key facts

Who runs it
Alliance for Clinical Trials in Oncology
Where
Albert Lea, Ames, Anaconda, Antigo, Augusta, Aurora, Bakersfield, Barrington, Bath, Bellevue, Bemidji, Billings, Bismarck, Bloomington, Boise, Boone, Bozeman, Bridgeport, Brunswick, Buffalo, Burlington, Canton, Cape Girardeau, Carthage, Cedar Rapids, Cherry Hill, Cheyenne, Chicago, Clive, Coeur d'Alene, Colorado Springs, Columbus, Council Bluffs, Crystal Lake, Cudahy, Damariscotta, Danville, Decatur, Denver, Des Moines, Dickson City, Dixon, Downers Grove, Dublin, Eau Claire, Effingham, Elgin, Erie, Eureka, Fargo, Farmington, Farrell, Forest Hills, Fort Dodge, Fremont, Fresno, Fruitland, Galesburg, Germantown, Gilbert, Grafton, Great Falls, Green Bay, Greensburg, Greer, Harrisburg, Hazel Crest, Honolulu, Jefferson, Jefferson Hills, Joplin, Kalispell, Kearney, Kenosha, Kewanee, La Crosse, Lafayette, Lake Success, Lakewood, Lewisburg, Libertyville, Little Rock, Lone Tree, Los Angeles, Macomb, Mankato, Marinette, Marshalltown, Martinsburg, Mattoon, Mechanicsburg, Medford, Menomonee Falls, Meridian, Milwaukee, Missoula, Modesto, Moline, Monroeville, Morgantown, Mount Vernon, Nampa, New York, Newport News, Normal, O'Fallon, Oak Creek, Oak Lawn, Oakland, Oklahoma City, Omaha, Oshkosh, Ottawa, Palos Heights, Park Ridge, Parkersburg, Pekin, Peoria, Peru, Philadelphia, Phoenix, Pittsburgh, Portland, Post Falls, Pottsville, Princeton, Racine, Rego Park, Rhinelander, Rochester, Roseville, Sacramento, Saint Cloud, Salt Lake City, San Francisco, San Jose, San Leandro, San Rafael, Sandpoint, Sanford, Santa Clara, Santa Rosa, Scarborough, Scottsdale, Seneca, Sewell, Sheboygan, Sioux Falls, South Jordan, South Portland, South San Francisco, Spartanburg, Springfield, St Louis, Stevens Point, Stony Brook, Summit, Surprise, Tempe, The Bronx, Two Rivers, Urbana, Vallejo, Walnut Creek, Washington, Wausau, Wauwatosa, West Allis, West Bend, Wexford, Wheeling, Wilkes-Barre, Willow Grove, and Wisconsin Rapids, United StatesSee the 216 sites
Trial code
Registry title
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Status
Recruiting
Phase
Phase 3
People taking part
228 people, planned
Started
5 Jun 2025
Expected to end
15 Apr 2031
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Gabapentin
  • Placebo
  • Chemotheraphy
  • Radiation Therapy
  • Analgesic Agent
  • Biospecimen Collection
  • Survey Administration
Record updated
4 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with squamous cell carcinoma of the head and neck who will start chemotherapy with cisplatin plus radiation and have had no earlier treatment for it.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Squamous cell carcinoma of the head and neck, stage I to IV.
Earlier treatment
No earlier treatment for head and neck cancer. No earlier surgery or radiation for it. Surgery and radioactive iodine for thyroid cancer in the past are fine. Planned treatment is cisplatin-based chemoradiation, weekly or every 3 weeks.

Main reasons for not taking part

  • Cancer that has come back, or being treated for recurrent head and neck cancer
  • Dialysis or a transplanted organ
  • Pregnant or nursing
  • Known brain metastases
  • Sleep apnea, or taking medicine for a psychotic illness

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Histologic documentation of disease: Squamous cell carcinoma of the head and neck region; Stage: I-IV
  • No prior treatment for head and neck cancer
  • Planned treatment with cisplatin-based chemoradiation therapy (weekly or once every 3 weeks [q 3 week])
  • Able to swallow capsules whole
  • No known hypersensitivity to gabapentin or its ingredients
  • No patients on dialysis or with transplanted organs
  • No prior surgery or radiation for head and neck cancer and/or are being treated for recurrent head and neck cancer. Patients with a history of surgery and radioactive iodine for the treatment of thyroid cancer are eligible. Concurrent cancer therapy for other cancers is not allowed
  • No planned surgery or chemotherapy or immunotherapy following 7 weeks of standard chemoradiation treatment
  • No known brain metastases
  • No nonprescribed use of any opioids (including heroin) within 6 months prior to registration
  • No prescribed medications for chronic and/or long-term pain and/or neuropathy, including patients under treatment of a pain specialist or substance abuse programs. Acute post-biopsy medications are allowed if the patient has discontinued them 3 days prior to study registration
  • No current treatment with mefloquine
  • Age ≥ 18 years
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
  • Creatinine ≤ 1.5 x upper limit of normal (ULN)
  • Not pregnant and not nursing, because this study involves both radiation and chemotherapy. In addition, the genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown. Therefore, for women of childbearing potential, a negative pregnancy test done < 7 days prior to registration is required. Women must agree to using contraception for the duration of receiving study drugs and for 6 months after completing chemoradiation
  • Not taking medications for a psychotic psychiatric illness
  • No existing diagnosis of sleep apnea
  • No acute narrow-angle glaucoma
  • No uncontrolled concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
  • No investigational agent within 30 days prior to registration
  • No enrollment on other studies of systemic pain control agents
  • Language: In order to complete the mandatory patient-completed measures, participants must be able to speak and read English or Spanish
  • Patients with impaired decision making are not eligible for study

Who cannot take part

  • -

Where in United States

  • Mayo Clinic Health System in Albert LeaAlbert Lea, United StatesContact: Lisa A. McGee (principal investigator)Taking people
  • Mary Greeley Medical CenterAmes, United StatesContact: Joseph J. Merchant (principal investigator)Taking people
  • McFarland Clinic - AmesAmes, United StatesContact: Joseph J. Merchant (principal investigator)Taking people
  • Community Hospital of AnacondaAnaconda, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • Aspirus Cancer Care-Antigo-Volm Cancer CenterAntigo, United StatesContact: Andrew J. Huang (principal investigator)Taking people
  • Harold Alfond Center for Cancer CareAugusta, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Advocate Outpatient Center - AuroraAurora, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Rush-Copley Medical CenterAurora, United StatesContact: Nancy GarciaNo longer taking part
  • AIS Cancer Center at San Joaquin Community HospitalBakersfield, United StatesContact: Luis Mariscal (principal investigator)Taking people
  • Advocate Good Shepherd HospitalBarrington, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • MaineHealth Coastal Cancer Treatment CenterBath, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Nebraska Medicine-BellevueBellevue, United StatesContact: Weining Zhen (principal investigator)Taking people
  • Sanford Joe Lueken Cancer CenterBemidji, United StatesContact: Daniel Almquist (principal investigator)Taking people
  • Billings Clinic Cancer CenterBillings, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • Sanford Bismarck Medical CenterBismarck, United StatesContact: Daniel Almquist (principal investigator)Taking people
  • Illinois CancerCare-BloomingtonBloomington, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Saint Luke's Cancer Institute - BoiseBoise, United StatesContact: Alison K. Conlin (principal investigator)Taking people
  • McFarland Clinic - BooneBoone, United StatesContact: Nancy GarciaNo longer taking part
  • Bozeman Health Deaconess HospitalBozeman, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • United Hospital CenterBridgeport, United StatesContact: David A. Clump (principal investigator)Taking people
  • MaineHealth Cancer Care and IV Therapy - BrunswickBrunswick, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Roswell Park Cancer InstituteBuffalo, United StatesContact: Anurag K. Singh (principal investigator)Taking people
  • Aurora Cancer Care-Southern Lakes VLCCBurlington, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Aultman Health FoundationCanton, United StatesContact: Daniel C. Sufficool (principal investigator)Taking people
  • Illinois CancerCare-CantonCanton, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Saint Francis Medical CenterCape Girardeau, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Illinois CancerCare-CarthageCarthage, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Mercy HospitalCedar Rapids, United StatesContact: Deborah W. Wilbur (principal investigator)Taking people
  • Oncology Associates at Mercy Medical CenterCedar Rapids, United StatesContact: Deborah W. Wilbur (principal investigator)Taking people
  • Saint Luke's HospitalCedar Rapids, United StatesContact: Candace R. Correa (principal investigator)Taking people
  • Jefferson Cherry Hill HospitalCherry Hill, United StatesContact: Voichita Bar Ad (principal investigator)Taking people
  • Memorial Hospital of Laramie CountyCheyenne, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • Advocate Illinois Masonic Medical CenterChicago, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Mercy Cancer Center-West LakesClive, United StatesContact: Richard L. Deming (principal investigator)Taking people
  • Kootenai Health - Coeur d'AleneCoeur d'Alene, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • Memorial Hospital NorthColorado Springs, United StatesContact: Mackenzie D. Daly (principal investigator)Taking people
  • UCHealth Memorial Hospital CentralColorado Springs, United StatesContact: Mackenzie D. Daly (principal investigator)Taking people
  • Ohio State University Comprehensive Cancer CenterColumbus, United StatesContact: Sung Jun Ma (principal investigator)Taking people
  • Methodist Jennie Edmundson HospitalCouncil Bluffs, United StatesContact: Nancy GarciaNo longer taking part
  • AMG Crystal Lake - OncologyCrystal Lake, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Aurora Saint Luke's South ShoreCudahy, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • MaineHealth LincolnHealth HospitalDamariscotta, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Carle at The RiverfrontDanville, United StatesContact: Daniel H. Barnett (principal investigator)Taking people
  • Geisinger Medical CenterDanville, United StatesContact: Fiori Alite (principal investigator)Taking people
  • Cancer Care Specialists of Illinois - DecaturDecatur, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Decatur Memorial HospitalDecatur, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Kaiser Permanente-FranklinDenver, United StatesContact: Matthew J. Eadens (principal investigator)Taking people
  • Mercy Medical Center - Des MoinesDes Moines, United StatesContact: Richard L. Deming (principal investigator)Taking people
  • Geisinger Cancer Center Dickson CityDickson City, United StatesContact: Fiori Alite (principal investigator)Taking people
  • Illinois CancerCare-DixonDixon, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Advocate Good Samaritan HospitalDowners Grove, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Kaiser Permanente DublinDublin, United StatesContact: Nancy GarciaNo longer taking part
  • Mayo Clinic Health System-Eau Claire ClinicEau Claire, United StatesContact: Lisa A. McGee (principal investigator)Taking people
  • Carle Physician Group-EffinghamEffingham, United StatesContact: Daniel H. Barnett (principal investigator)Taking people
  • Crossroads Cancer CenterEffingham, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Advocate Sherman HospitalElgin, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Saint Vincent HospitalErie, United StatesContact: Larisa Greenberg (principal investigator)Taking people
  • UPMC Hillman Cancer Center ErieErie, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • Illinois CancerCare-EurekaEureka, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Sanford Broadway Medical CenterFargo, United StatesContact: Daniel Almquist (principal investigator)Taking people
  • Sanford Roger Maris Cancer CenterFargo, United StatesContact: Daniel Almquist (principal investigator)Taking people
  • Farmington Health CenterFarmington, United StatesContact: Ying J. Hitchcock (principal investigator)Taking people
  • UPMC Cancer Center at UPMC HorizonFarrell, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • Northwell Health Physicians Partners Radiation Medicine at QueensForest Hills, United StatesContact: Bhupesh Parashar (principal investigator)Taking people
  • McFarland Clinic - Trinity Cancer CenterFort Dodge, United StatesContact: Joseph J. Merchant (principal investigator)Taking people
  • Kaiser Permanente-FremontFremont, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente Fresno Orchard PlazaFresno, United StatesContact: Nancy GarciaNo longer taking part
  • Saint Luke's Cancer Institute - FruitlandFruitland, United StatesContact: Alison K. Conlin (principal investigator)Taking people
  • Illinois CancerCare-GalesburgGalesburg, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Aurora Health Care Germantown Health CenterGermantown, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Arizona Center for Cancer Care - GilbertGilbert, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • Aurora Cancer Care-GraftonGrafton, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Benefis Sletten Cancer InstituteGreat Falls, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • Aurora BayCare Medical CenterGreen Bay, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • UPMC Cancer Centers - Arnold Palmer PavilionGreensburg, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • Gibbs Cancer Center-PelhamGreer, United StatesContact: Amarinthia (Amy) Curtis (principal investigator)Taking people
  • UPMC Pinnacle Cancer Center/Community Osteopathic CampusHarrisburg, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • Advocate South Suburban HospitalHazel Crest, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Kaiser Permanente Moanalua Medical CenterHonolulu, United StatesContact: Nancy GarciaNo longer taking part
  • McFarland Clinic - JeffersonJefferson, United StatesContact: Nancy GarciaNo longer taking part
  • Jefferson HospitalJefferson Hills, United StatesContact: Larisa Greenberg (principal investigator)Taking people
  • Freeman Health SystemJoplin, United StatesContact: Jay W. Carlson (principal investigator)Taking people
  • Logan Health Medical CenterKalispell, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • CHI Health Good SamaritanKearney, United StatesContact: Nancy GarciaNo longer taking part
  • Aurora Cancer Care-Kenosha SouthKenosha, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Illinois CancerCare-Kewanee ClinicKewanee, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Gundersen Lutheran Medical CenterLa Crosse, United StatesContact: Michael O. Ojelabi (principal investigator)Taking people
  • Mayo Clinic Health System-Franciscan HealthcareLa Crosse, United StatesContact: Lisa A. McGee (principal investigator)Taking people
  • Kaiser Permanente-Rock CreekLafayette, United StatesContact: Matthew J. Eadens (principal investigator)Taking people
  • Northwell Health/Center for Advanced MedicineLake Success, United StatesContact: Bhupesh Parashar (principal investigator)Taking people
  • CommonSpirit Saint Anthony Hospital Cancer CenterLakewood, United StatesContact: Shahzad Siddique (principal investigator)Taking people
  • Geisinger Medical Oncology-LewisburgLewisburg, United StatesContact: Fiori Alite (principal investigator)Taking people
  • AMG Libertyville - OncologyLibertyville, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Condell Memorial HospitalLibertyville, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • University of Arkansas for Medical SciencesLittle Rock, United StatesContact: Santanu Samanta (principal investigator)Taking people
  • Kaiser Permanente-Lone TreeLone Tree, United StatesContact: Matthew J. Eadens (principal investigator)Taking people
  • Los Angeles General Medical CenterLos Angeles, United StatesContact: Adam Garsa (principal investigator)Taking people
  • USC / Norris Comprehensive Cancer CenterLos Angeles, United StatesContact: Adam Garsa (principal investigator)Taking people
  • Illinois CancerCare-MacombMacomb, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Mayo Clinic Health Systems-MankatoMankato, United StatesContact: Lisa A. McGee (principal investigator)Taking people
  • Aurora Bay Area Medical Group-MarinetteMarinette, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • McFarland Clinic - MarshalltownMarshalltown, United StatesContact: Joseph J. Merchant (principal investigator)Taking people
  • WVUH-Berkely Medical CenterMartinsburg, United StatesContact: David A. Clump (principal investigator)Taking people
  • Carle Physician Group-Mattoon/CharlestonMattoon, United StatesContact: Daniel H. Barnett (principal investigator)Taking people
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer PavilionMechanicsburg, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • Aspirus Medford HospitalMedford, United StatesContact: Andrew J. Huang (principal investigator)Taking people
  • Froedtert Menomonee Falls HospitalMenomonee Falls, United StatesContact: Monica E. Shukla (principal investigator)Taking people
  • Saint Luke's Cancer Institute - MeridianMeridian, United StatesContact: Alison K. Conlin (principal investigator)Taking people
  • Aurora Cancer Care-MilwaukeeMilwaukee, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Aurora Saint Luke's Medical CenterMilwaukee, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Aurora Sinai Medical CenterMilwaukee, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Medical College of WisconsinMilwaukee, United StatesContact: Monica E. Shukla (principal investigator)Taking people
  • Community Medical CenterMissoula, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • Kaiser Permanente- Modesto MOB IIModesto, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente-ModestoModesto, United StatesContact: Nancy GarciaNo longer taking part
  • Trinity Medical CenterMoline, United StatesContact: Daniel H. Barnett (principal investigator)Taking people
  • Forbes HospitalMonroeville, United StatesContact: Larisa Greenberg (principal investigator)Taking people
  • UPMC Cancer Center - MonroevilleMonroeville, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • UPMC Hillman Cancer Center - MonroevilleMonroeville, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • West Virginia University HealthcareMorgantown, United StatesContact: David A. Clump (principal investigator)Taking people
  • SSM Health Good SamaritanMount Vernon, United StatesContact: Jay W. Carlson (principal investigator)Taking people
  • Saint Luke's Cancer Institute - NampaNampa, United StatesContact: Alison K. Conlin (principal investigator)Taking people
  • Lenox Hill HospitalNew York, United StatesContact: Bhupesh Parashar (principal investigator)Taking people
  • Manhattan Eye Ear and Throat HospitalNew York, United StatesContact: Bhupesh Parashar (principal investigator)Taking people
  • Peninsula Cancer Institute-Newport NewsNewport News, United StatesContact: Masey M. Ross (principal investigator)Taking people
  • Carle BroMenn Medical CenterNormal, United StatesContact: Daniel H. Barnett (principal investigator)Taking people
  • Carle Cancer Institute NormalNormal, United StatesContact: Daniel H. Barnett (principal investigator)Taking people
  • Cancer Care Center of O'FallonO'Fallon, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • HSHS Saint Elizabeth's HospitalO'Fallon, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Drexel Town Square Health CenterOak Creek, United StatesContact: Monica E. Shukla (principal investigator)Taking people
  • Advocate Christ Medical CenterOak Lawn, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Advocate Outpatient Center - Oak LawnOak Lawn, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Kaiser Permanente-OaklandOakland, United StatesContact: Nancy GarciaNo longer taking part
  • University of Oklahoma Health Sciences CenterOklahoma City, United StatesContact: Christina Henson (principal investigator)Taking people
  • Nebraska Medicine-Village PointeOmaha, United StatesContact: Weining Zhen (principal investigator)Taking people
  • University of Nebraska Medical CenterOmaha, United StatesContact: Weining Zhen (principal investigator)Taking people
  • Nebraska Methodist HospitalOmaha, United StatesContact: Nancy GarciaNo longer taking part
  • Vince Lombardi Cancer Clinic - OshkoshOshkosh, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Illinois CancerCare-Ottawa ClinicOttawa, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Advocate High Tech Medical ParkPalos Heights, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Advocate Lutheran General HospitalPark Ridge, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Camden Clark Medical CenterParkersburg, United StatesContact: David A. Clump (principal investigator)Taking people
  • Illinois CancerCare-PekinPekin, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Arizona Center for Cancer Care-PeoriaPeoria, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • Illinois CancerCare-PeoriaPeoria, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Illinois CancerCare-PeruPeru, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Jefferson Torresdale HospitalPhiladelphia, United StatesContact: Voichita Bar Ad (principal investigator)Taking people
  • Thomas Jefferson University HospitalPhiladelphia, United StatesContact: Voichita Bar Ad (principal investigator)Taking people
  • Arizona Center for Cancer Care - BiltmorePhoenix, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • Arizona Center for Cancer Care - PhoenixPhoenix, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • Mayo Clinic Hospital in ArizonaPhoenix, United StatesContact: Lisa A. McGee (principal investigator)Taking people
  • Allegheny General HospitalPittsburgh, United StatesContact: Larisa Greenberg (principal investigator)Taking people
  • UPMC Hillman Cancer CenterPittsburgh, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • UPMC-Saint Clair Hospital Cancer CenterPittsburgh, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • UPMC-Shadyside HospitalPittsburgh, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • MaineHealth Maine Medical Center - PortlandPortland, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Kootenai Clinic Cancer Services - Post FallsPost Falls, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • Geisinger Cancer Services-PottsvillePottsville, United StatesContact: Fiori Alite (principal investigator)Taking people
  • Illinois CancerCare-PrincetonPrinceton, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Princeton Community HospitalPrinceton, United StatesContact: David A. Clump (principal investigator)Taking people
  • Aurora Cancer Care-RacineRacine, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Queens Cancer CenterRego Park, United StatesContact: Bhupesh Parashar (principal investigator)Taking people
  • Aspirus Cancer Care-Rhinelander-James Beck Cancer CenterRhinelander, United StatesContact: Andrew J. Huang (principal investigator)Taking people
  • Mayo Clinic in RochesterRochester, United StatesContact: Lisa A. McGee (principal investigator)Taking people
  • Kaiser Permanente-RosevilleRoseville, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente Downtown CommonsSacramento, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente-South SacramentoSacramento, United StatesContact: Nancy GarciaNo longer taking part
  • Coborn Cancer Center at Saint Cloud HospitalSaint Cloud, United StatesContact: Donald J. Jurgens (principal investigator)Taking people
  • Huntsman Cancer Institute/University of UtahSalt Lake City, United StatesContact: Ying J. Hitchcock (principal investigator)Taking people
  • University of Utah Sugarhouse Health CenterSalt Lake City, United StatesContact: Ying J. Hitchcock (principal investigator)Taking people
  • Kaiser Permanente-San FranciscoSan Francisco, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente-Santa Teresa-San JoseSan Jose, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente San LeandroSan Leandro, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser San Rafael-GallinasSan Rafael, United StatesContact: Nancy GarciaNo longer taking part
  • Kootenai Clinic Cancer Services - SandpointSandpoint, United StatesContact: John M. Schallenkamp (principal investigator)Taking people
  • MaineHealth Cancer Care Center of York CountySanford, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Kaiser Permanente Medical Center - Santa ClaraSanta Clara, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente-Santa RosaSanta Rosa, United StatesContact: Nancy GarciaNo longer taking part
  • MaineHealth Maine Medical Center- ScarboroughScarborough, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Arizona Center for Cancer Care - OsbornScottsdale, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • Arizona Center for Cancer Care - ScottsdaleScottsdale, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • UPMC Cancer Center at UPMC NorthwestSeneca, United StatesContact: Dan P. Zandberg (principal investigator)Taking people
  • Sidney Kimmel Cancer Center Washington TownshipSewell, United StatesContact: Voichita Bar Ad (principal investigator)Taking people
  • Vince Lombardi Cancer Clinic-SheboyganSheboygan, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Sanford Cancer Center Oncology ClinicSioux Falls, United StatesContact: Daniel Almquist (principal investigator)Taking people
  • Sanford USD Medical Center - Sioux FallsSioux Falls, United StatesContact: Daniel Almquist (principal investigator)Taking people
  • South Jordan Health CenterSouth Jordan, United StatesContact: Ying J. Hitchcock (principal investigator)Taking people
  • MaineHealth Cancer Care and IV Therapy - South PortlandSouth Portland, United StatesContact: Vatche Tchekmedyian (principal investigator)Taking people
  • Kaiser Permanente-South San FranciscoSouth San Francisco, United StatesContact: Nancy GarciaNo longer taking part
  • Spartanburg Medical CenterSpartanburg, United StatesContact: Amarinthia (Amy) Curtis (principal investigator)Taking people
  • Southern Illinois University School of MedicineSpringfield, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Springfield ClinicSpringfield, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Springfield Memorial HospitalSpringfield, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Mercy Hospital Saint LouisSt Louis, United StatesContact: Jay W. Carlson (principal investigator)Taking people
  • Mercy Hospital SouthSt Louis, United StatesContact: Jay W. Carlson (principal investigator)Taking people
  • Aspirus Cancer Care - Stevens PointStevens Point, United StatesContact: Andrew J. Huang (principal investigator)Taking people
  • Stony Brook University Medical CenterStony Brook, United StatesContact: Kartik M. Mani (principal investigator)Taking people
  • Aurora Medical Center in SummitSummit, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Arizona Center for Cancer Care-SurpriseSurprise, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • Arizona Center for Cancer CareTempe, United StatesContact: Cory W. Heal (principal investigator)Taking people
  • Montefiore Medical Center - Moses CampusThe Bronx, United StatesContact: Rafi Kabarriti (principal investigator)Taking people
  • Montefiore Medical Center-Einstein CampusThe Bronx, United StatesContact: Rafi Kabarriti (principal investigator)Taking people
  • Vince Lombardi Cancer Clinic-Two RiversTwo Rivers, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Carle Cancer CenterUrbana, United StatesContact: Daniel H. Barnett (principal investigator)Taking people
  • Kaiser Permanente-VallejoVallejo, United StatesContact: Nancy GarciaNo longer taking part
  • Kaiser Permanente-Walnut CreekWalnut Creek, United StatesContact: Nancy GarciaNo longer taking part
  • Illinois CancerCare - WashingtonWashington, United StatesContact: Bryan A. Faller (principal investigator)Taking people
  • Aspirus Cancer Care-WausauWausau, United StatesContact: Andrew J. Huang (principal investigator)Taking people
  • Aurora Cancer Care-Milwaukee WestWauwatosa, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Aurora West Allis Medical CenterWest Allis, United StatesContact: Thomas J. Saphner (principal investigator)Taking people
  • Froedtert West Bend Hospital/Kraemer Cancer CenterWest Bend, United StatesContact: Monica E. Shukla (principal investigator)Taking people
  • Wexford Health and Wellness PavilionWexford, United StatesContact: Larisa Greenberg (principal investigator)Taking people
  • Wheeling Hospital/Schiffler Cancer CenterWheeling, United StatesContact: David A. Clump (principal investigator)Taking people
  • Geisinger Wyoming Valley/Henry Cancer CenterWilkes-Barre, United StatesContact: Fiori Alite (principal investigator)Taking people
  • Asplundh Cancer PavilionWillow Grove, United StatesContact: Voichita Bar Ad (principal investigator)Taking people
  • Aspirus Cancer Care - Wisconsin RapidsWisconsin Rapids, United StatesContact: Andrew J. Huang (principal investigator)Taking people

About the trial

What the trial wants to find out

This phase III trial tests if gabapentin can prevent the need for opiate pain medication for mouth sores (oral mucositis) in patients undergoing treatment with chemotherapy and radiation for squamous cell carcinoma of the head and neck region. Oral mucositis is a common side effect of radiation treatment and can cause severe pain, dysphagia, and weight loss resulting in feeding tube placement, worse health-related quality of life, treatment interruptions, unplanned hospitalizations, and significant financial burden. Mucositis pain is often treated with opioid pain medications which do provide pain relief but have many known side effects not limited to mental clouding, constipation, fatigue, endocrinopathy, neurotoxicity, sleep-disordered breathing, and most distressingly persistent opioid use. Gabapentin may help relieve pain from oral mucositis caused by radiation while also reducing the need for opiate pain medications for patients receiving chemotherapy and radiation for squamous cell carcinoma of the head and neck region

The 2 groups in the trial

  • Arm I (Placebo)Placebo, for comparison

    Starting by radiation treatment 8, patients receive placebo PO QD on day 1, BID on day 2, then TID starting day 3 onward. Patients also receive standard of care radiation, chemotherapy and pain medications. Treatment with placebo continues in the absence of disease progression or unacceptable toxicity, until the symptoms of oral mucositis and other treatment effects begin to resolve and other pain medications has been stopped. Patients then continue to receive placebo TID for 9 additional days, at sequentially smaller doses, then BID for 1 day and QD for one day before stopping. Patients undergo blood sample collection throughout the study.

    Treatment: Placebo, Chemotheraphy, Radiation Therapy, Analgesic Agent, Biospecimen Collection, and Survey Administration

  • Arm II (Gabapentin)Treatment being tested

    Starting by radiation treatment 8, patients receive gabapentin PO QD on day 1, BID on day 2, then TID starting day 3 onward. Patients also receive standard of care radiation, chemotherapy and pain medications. Treatment with gabapentin continues in the absence of disease progression or unacceptable toxicity, until the symptoms of oral mucositis and other treatment effects begin to resolve and other pain medications has been stopped. Patients then continue to receive gabapentin TID for 9 additional days, at sequentially smaller doses, then BID for 1 day and QD for one day before stopping. Patients undergo blood sample collection throughout the study.

    Treatment: Gabapentin, Chemotheraphy, Radiation Therapy, Analgesic Agent, Biospecimen Collection, and Survey Administration

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial
Plain-language title
Gabapentin to prevent opioid use for mouth sore pain in head and neck cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
4 November 2026